Qureator

Pre-clinical

San Francisco, United StatesFounded 2021qureator.com

Qureator provides integrated human disease model and AI platform to evaluate treatment efficacy in complex disease models.

Market Cap

Private

Pipeline

—

Patents

—

Publications

—

Private Company

Total funding raised: $2.5M

Qureator provides integrated human disease model and AI platform to evaluate treatment efficacy in complex disease models.

Synthetic BiologyAI / Machine Learning

Total raised:$2.5M

Seed$2.5MUndisclosedMar 15, 2021